CN Patent

CN112805238A — 无水硫代硫酸钠和其调配物

Assigned to Fenac Pharmaceutical Co ltd · Expires 2021-05-14 · 5y expired

What this patent protects

本文描述了无水硫代硫酸钠、用于合成无水硫代硫酸钠的方法、其药物组合物和治疗耳毒性的方法。无水硫代硫酸钠由亚硫酸钠、硫和氯化十六烷基吡啶合成。所述无水硫代硫酸钠被调配成包括缓冲剂和溶剂的药物组合物。这些组合物可用于消除或降低接受基于铂的化学治疗药物的小儿患者的耳毒性。

USPTO Abstract

本文描述了无水硫代硫酸钠、用于合成无水硫代硫酸钠的方法、其药物组合物和治疗耳毒性的方法。无水硫代硫酸钠由亚硫酸钠、硫和氯化十六烷基吡啶合成。所述无水硫代硫酸钠被调配成包括缓冲剂和溶剂的药物组合物。这些组合物可用于消除或降低接受基于铂的化学治疗药物的小儿患者的耳毒性。

Drugs covered by this patent

Sodium Thiosulfate (SODIUM THIOSULFATE) · Us Army

Patent Metadata

Patent number: CN112805238A
Jurisdiction: CN
Classification: —
Expires: 2021-05-14
Drug substance claim: No
Drug product claim: No
Assignee: Fenac Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.